Literature DB >> 15264122

Dydrogesterone-induced hepatitis and autoimmune hemolytic anemia.

Engin Altintaş1, Dilek Oğuz, Sabite Kaçar, Yasemin Ozderin, Orhan Sezgin, Neslihan Inci Zengin.   

Abstract

Dydrogesterone, similar to women's natural progesterone, has been used in a wide range of gynecological conditions. Despite its widespread use, dydrogesterone-induced hepatotoxicity and dydrogesterone-induced hemolytic anemia have, to the best of our knowledge, never been reported previously. We describe a case of hepatitis and warm antibody hemolytic anemia due to dydrogesterone.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15264122

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN： 1300-4948            Impact factor:   1.852


  3 in total

1.  Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.

Authors:  Edeltraut Garbe; Frank Andersohn; Elisabeth Bronder; Abdulgabar Salama; Andreas Klimpel; Michael Thomae; Hubert Schrezenmeier; Martin Hildebrandt; Ernst Späth-Schwalbe; Andreas Grüneisen; Oliver Meyer; Hanife Kurtal
Journal:  Eur J Clin Pharmacol       Date:  2011-12-21       Impact factor: 2.953

Review 2.  Hepatotoxicity from green tea: a review of the literature and two unpublished cases.

Authors:  Gabriela Mazzanti; Francesca Menniti-Ippolito; Paola Angela Moro; Federica Cassetti; Roberto Raschetti; Carmela Santuccio; Sabina Mastrangelo
Journal:  Eur J Clin Pharmacol       Date:  2009-02-06       Impact factor: 2.953

3.  Delayed Fulminant Hepatic Failure from Dydrogesterone-Related In Vitro Fertilization Therapy Requiring Liver Transplantation During Pregnancy.

Authors:  Jacques A J Malherbe; George Garas; Tze S Khor; Gerry C MacQuillan
Journal:  Am J Case Rep       Date:  2020-09-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.